| Jurisdiction | Restriction | ||||
|---|---|---|---|---|---|
| Minimum fibrosis stage required | Substance use | HIV coinfection | Prescriber | Decompensated cirrhosis | |
| Province/territory | |||||
| British Columbia | F2 | None listed | None listed | General practitioner | None listed |
| Alberta | F2 | None listed | None listed | None listed | Ineligible |
| Saskatchewan | F2 | None listed | None listed | General practitioner | None listed |
| Manitoba | F2 | None listed | Eligible | Specialist | Ineligible |
| Ontario | F2 | None listed | Eligible | General practitioner | Ineligible |
| Quebec | None listed* | None listed | Ineligible† | None listed | None listed |
| New Brunswick | F2 | None listed | None listed | None listed | Ineligible |
| Nova Scotia | F2 | None listed | None listed | Specialist‡ | Ineligible |
| Prince Edward Island | NA | NA | NA | NA | NA |
| Newfoundland and Labrador | F2 | None listed | None listed | None listed | Ineligible |
| Yukon | F2 | None listed | None listed | Specialist | Ineligible |
| Northwest Territories | F2 | None listed | None listed | Specialist‡ | None listed |
| Nunavut | F2 | None listed | None listed | Specialist‡ | None listed |
| Federal | |||||
| Non-Insured Health Benefits Program | F2 | None listed | None listed | Specialist‡ | None listed |
| Correctional Service Canada | F2§ | None listed¶ | None listed | None listed | None listed |
Note: NA = not available.
*However, coauthors indicated that in practice there were no fibrosis stage restrictions.
†However, exceptions could be granted via the "patient d'exception" (exception patient) measure.
‡None listed in criteria; however, a specialist prescription was required for peginterferon-based treatments.
§Treatment prioritized to patients with stage F3 or F4 fibrosis; treatment for those with stage F0, F1 or F2 fibrosis was reviewed on a case-by-case basis.
¶Directly observed therapy required.